Day: February 7, 2022

Sedgwick University expands world-class training to Australia

SYDNEY, Feb. 8, 2022 /PRNewswire/ — Sedgwick, a leading global provider of technology-enabled risk, benefits and integrated business solutions, will begin offering its acclaimed Sedgwick University training programs in Australia to develop, upskill, and attract the next generation of claims professionals. In December 2021, Sedgwick University rolled out the plans for a global footprint to provide state-of-the-art […]

First ever cohort of FutureLearn Scholars announced

Four learners from Ghana, Russia, Uganda and Nigeria to receive world-class online education, £5,000 of funding, and career mentoring LONDON, Feb. 8, 2022 /PRNewswire/ — – the global learning platform with a mission to transform access to education – is proud to announce the first cohort of FutureLearn Scholars. The inaugural FutureLearn Scholarship was […]

Bridge Biotherapeutics and Scripps Research Launch Research Collaboration to Develop Discovery Platform and Novel Covalent Probes Based on Chemical Biology and Chemoproteomics

Two-year research collaboration to develop new reactive group chemistries targeting non-cysteine amino acids to expand druggable binding sites and identify novel targets in oncology and immunology Collaborators at Scripps are pioneers in the field of chemical biology and chemistry SEONGNAM, South Korea and SAN DIEGO, Calif., Feb. 8, 2022 /PRNewswire/ — Bridge Biotherapeutics (KQ288330), a South Korean […]

mRNA COVID-19 Vaccines are Safe for People with Cancer According to New Study in JNCCN

Researchers at Fox Chase Cancer Center conducted the largest published, peer-reviewed, study to-date examining the short-term adverse effects of mRNA COVID-19 vaccination in patients with cancer—finding they experienced no more, and no different, side effects compared to non-cancer patients. PLYMOUTH MEETING, Pa., Feb. 8, 2022 /PRNewswire/ — New research in the February 2022 issue of […]

IonOpticks enters OEM partnership with Bruker that sets a new standard for mass spectrometry-based research

MELBOURNE, Australia, Feb. 8, 2022 /PRNewswire/ — Premium manufacturer of chromatography for proteomics applications, IonOpticks, has entered an OEM partnership with the Bruker Corporation (Nasdaq: BRKR), allowing Bruker to expand their portfolio of 4D-Proteomics solutions with the release of the Bruker Focus Series columns which will leverage the technology of IonOpticks’ revolutionary Aurora Series columns. […]

Covaris AFA-energetics™ Enables True Automated Total Nucleic Acid Extraction and Purification Workflows from FFPE Tissues

A fully automated, high-throughput deparaffinization and total Nucleic Acids extraction and purification kit for FFPE samples WOBURN, Mass., Feb. 7, 2022 /PRNewswire/ — Covaris, LLC (“Covaris” or “the Company”), a manufacturer of advanced tools enabling life science innovations, announced the launch of a fully automated, high-throughput deparaffinization and total nucleic acids extraction kit for formalin-fixed paraffin-embedded […]

Binance Unites J Balvin, Jimmy Butler and Valentina Shevchenko to Take on Big Game Crypto Ads, Invites Fans to Sound the #CryptoCelebAlert and Trust Themselves to Learn Crypto

World’s leading blockchain ecosystem launches consumer empowerment campaign with gameday POAP NFT giveaway DUBAI, UAE, Feb. 7, 2022 /PRNewswire/ — It won’t just be a battle between teams and fans this weekend – crypto companies will be going head-to-head. Brands are recruiting notable faces to promote everything from NFTs to Web3 technologies while Binance, the world’s […]

US FDA Study May Proceed letter for Clarity’s Cu-64 SAR-bisPSMA trial in prostate cancer

SYDNEY, Feb. 7, 2022 /PRNewswire/ — Clarity Pharmaceuticals (ASX: CU6) (“Clarity”), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, is pleased to announce that it has received a confirmation from the US Food and Drug Administration (FDA) that the diagnostic 64Cu SAR-bisPSMA trial (COBRA) may proceed. Clarity’s Executive Chairman, Dr […]

Back To Top